Abstract
The anti-infective market is at a critical juncture. For the past 60 years,
antibiotic drugs have turned bacterial infections into treatable conditions
rather than the life-threatening scourges they once were. But the
effectiveness of many antibiotics is waning dramatically, as more and more
types of bacteria become resistant to them.
This Kalorama Information The World Market for Anti-Infectives considers the
anti-infective drug market as it faces challenges with resistance and generic
competition.
The report focuses on three key segments of treatment:
- Antifungals (Allylamines, Azoles,Polyene Macrolides and Other
Antifungals)
- Antibacterials (Cephalosporins, Macrolides, Penicillins, Quinolones,
Sulfonamides, Tetracyclines, Carbopenems, Miscellaneous)
- Antivirals (Nucleoside Analogs, Transcriptase Inhibitors, DNA
Polymerase Inhibitors, Protease Inhibitors)
For each category and each subsegment, current market and forecast is
provided. The report covers both currently marketed and late stage development
products.. Revenues for each segment were generated using dollar sales for
each product.
The report includes statistical information for infections by type worldwide,
with special emphasis on the U.S. and Europe.
As part of its coverage the report provides:
- Overview
- Description of Products on the Market
- Review of Products in Late Stage Development
- Market Estimates and Forecasts
- Competitive Analysis of Leading Providers
- Regional Breakdown of Antifungal, Antibacterial and Antiviral Market
(US, Europe and Asia)
- Market Share of Antifungal, Antibacterial and Antiviral Market
The information for this report was gathered using both primary and secondary
research including comprehensive research of secondary sources such as company
literature, databases, investment reports, and medical and business journals
focused on the anti-infective industry. Telephone interviews and email
correspondence were the primary method of gathering information. For the
purpose of this study Kalorama Information conducted interviews with key
industry officials, consultants, health care providers, and government
personnel. These sources were the primary basis in gathering information
specifically relating to revenue and market share data presented in this
report. Specific interviews with pharmaceutical company representatives
included marketing directors, division managers, and product representatives.
| 
View Cart
